Intraocular Pressure, Safety, and Quality of Life in Glaucoma Patients Switching to Latanoprost from Monotherapy Treatments

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 5, 2003, Pages 405-415

  Zimmerman, Thom J ^a,b   Stewart, William C ^c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b PFIZER INC   (United States)

^c Pharmaceutical Res Network LLC   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ARTICLE; BACKACHE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EYE BURN; EYE IRRITATION; EYE PAIN; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPEREMIA; HYPERPIGMENTATION; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE; IRITIS; KERATITIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RETINA MACULA CYSTOID EDEMA; SIDE EFFECT; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0142152334     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803322472971     Document Type: Article

References (13)

1. Book, S.A. Essentials of Statistics. New York: McGraw Hill, 1978: 117-122; 205-215.
2. Mundorf, T.K., Cate, E.A., Sine, C.S., Otero, D.W., Stewart, J.A., and Stewart, W.C. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J. Ocular Pharmacol. Ther. 14:129-135, 1998.
3. Duff, G.R. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure. Acta Ophthalmol. (Copenh) 65(5):618-621, 1987.
4. Siegel, S. Non Parametric Statistics. Series in Psychology. New York: McGraw-Hill, 1956: 63-67.
5. Alm, A., and Stjernschantz, J. Effects on intraocular pressure and side-effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology. 102:1743-1752, 1995.
6. Camras, C.B. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology. 103:138-147, 1996.
7. Watson, P., and Stjernschantz, J. A six-month, randomised, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 103:126-137, 1996.
8. Diestelhorst, M., Nordmann, J.P., and Toris, C.B. Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy. Surv. Ophthalmol. 47(suppl. 1):S155-S161, 2002.
9. Netland, P.A., Landry, T., Sullivan, E.K., Andrew, R., Silver, L., Weiner, A., Mallick, S., Dickerson, J., Bergamini, M.V., Robertson, S.M., Davis, A.A., and the Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am. J. Ophthalmol. 132:472-484, 2001.
10. Dubiner, H., Cooke, D., Dirks, M., Stewart, W.C., Vandenburgh, A.M., and Felix, C. Efficacy and safety of bimatoprost in patients with elevated, intraocular pressure: a 30-day comparison with latanoprost. Surv. Ophthalmol. 45(suppl. 4):S353-S360, 2002.
11. Noecker, R.S., Dirks, M.S., Choplin, N.T., Bernstein, P., Batoosingh, A.L., and Whitcup, S.M., for the Bimatoprost/Latanoprost Study Group. A six-month randomised clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am. J. Ophthalmol. 135:55-63, 2003.
12. Stewart, W.C., Day, D.G., Stewart, J.A., Holmes, K.T., Leech, J.N., Rowan, C.T., and Schwartz, G.F. Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension. J. Ocular Pharmacol. Ther. 16:557-564, 2000.
13. Wistrand, P.J., Stjernschantz, J., and Olsson, K. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Surv. Ophthalmol. 41(Suppl 2):S129-138, 1997.